Glycopeptide resistance has been studied in detail in enterococci and staphylococci. In these microorganisms, high-level resistance is achieved by replacing the C-terminal D-alanyl-D-alanine of the nascent peptidoglycan with D-alanyl-D-lactate or D-alanyl-D-serine, thus reducing the affinities of glycopeptides for cell wall targets. Reorganization of the cell wall is directed by the expression of the van gene clusters. The identification of van gene homologs in the genomes of several glycopeptide-producing actinomycetes suggests the involvement of a similar self-resistance mechanism to avoid suicide. This report describes a comprehensive study of self-resistance in Actinoplanes teichomyceticus ATCC 31121, the producer of the clinically relevant glycopeptide teicoplanin. A. teichomyceticus ATCC 31121 showed a MIC of teicoplanin of 25 g/ml and a MIC of vancomycin of 90 g/ml during vegetative growth. The vanH, vanA, and vanX genes of A. teichomyceticus were found to be organized in an operon whose transcription was constitutive. Analysis of the UDP-linked peptidoglycan precursors revealed the presence of UDP-glycomuramyl pentadepsipeptide terminating in D-alanyl-D-lactate. No trace of precursors ending in D-alanyl-D-alanine was detected. Thus, the van gene complex was transcribed and expressed in the genetic background of A. teichomyceticus and conferred resistance to vancomycin and teicoplanin through the modification of cell wall biosynthesis. During teicoplanin production (maximum productivity, 70 to 80 g/ml), the MIC of teicoplanin remained in the range of 25 to 35 g/ml. Teicoplanin-producing cells were found to be tolerant to high concentrations of exogenously added glycopeptides, which were not bactericidal even at 5,000 g/ml.
Glycopeptide antibiotics are produced by actinomycetes and inhibit the synthesis of bacterial cell wall by blocking peptidoglycan assembly. They bind to the D-alanyl-D-alanine (DAla-D-Ala) C terminus of the nascent peptidoglycan and prevent it from being utilized in the following cross-linking reactions catalyzed by transglycosylases and transpeptidases (18, 38, 44) . The structurally related glycopeptides vancomycin and teicoplanin have been used in clinical settings since 1958 and 1988, respectively. These drugs are still extensively used against multiresistant enterococci and methicillin-resistant staphylococci. Concern about vancomycin-resistant enterococci has been increasing during the last decade, and highly vancomycin resistant Staphylococcus aureus isolates have recently appeared in clinical specimens (10, 11) .
Two resistance phenotypes, VanA and VanB, have been extensively studied in enterococci and are considered of main importance, since the genes responsible for resistance (van genes) are inducible and transferable and confer high-level resistance to vancomycin (at concentrations up to 1,000 g/ml or more) (42) . The vanA gene cluster also confers high-level resistance to teicoplanin (4, 9, 15, 16) . Other resistant phenotypes among enterococci (VanC, VanD, VanE, and VanG) showing a lower level of resistance to vancomycin and none or poor resistance to teicoplanin have been described (reviewed in reference 42). In VanA, VanB, and VanD enterococci, van genes direct the synthesis of peptidoglycan precursors terminating in the depsipeptide D-alanyl-D-lactate (D-Ala-D-Lac), whereas in VanC, VanE, and VanG strains, the C-terminal end is D-alanyl-D-serine (D-Ala-D-Ser) in place of the usual D-Ala-D-Ala. The modification of the target drastically reduces affinity for the glycopeptide, thus producing resistance (38) . The key enzymes in VanA and VanB enterococci are a dehydrogenase (VanH encoded by the vanH/vanH B gene) that converts pyruvate into D-lactate (9, 16) , a ligase (VanA or VanB encoded by the respective van gene) that joins D-alanine and D-lactic acid (9, 16, 34) , and a D,D-dipeptidase (VanX encoded by the vanX/vanX B gene) that cleaves the D-Ala-D-Ala produced by the normal peptidoglycan synthesis pathway (16, 45, 51) . The genes vanH, vanA/vanB, and vanX are organized in a cluster and are often associated with other genes encoding additional but not essential functions (1, 3, 15, 17, 50) . A two-component regulatory system, composed of a membraneassociated sensor kinase (VanS or VanS B ) and a cytoplasmic response regulator that acts as a transcriptional activator (VanR or VanR B ), regulates the expression of vanH, vanA/vanB, and vanX (5) .
An intriguing hypothesis is that bacterial pathogens have actually acquired antibiotic resistance mechanisms from antibiotic producers, although there is no conclusive evidence which proves gene transfer (19, 39, 40) . In fact, van-like genes with a high level of homology and an organization similar to those of the pathogenic enterococci have been identified in glycopeptide-producing actinomycetes (28, (30) (31) (32) (33) , in which they might play a role in avoiding self-inhibition during antibiotic production. van-like genes are present in glycopeptide producers, such as Amycolatopsis spp., which are producers of vancomycin, chloroeremomycin, ristocetin, and avoparcin (30) ; in Streptomyces toyocaensis NRRL15009, which is the producer of A47934 (43) ; and in the teicoplanin producer Actinoplanes teichomyceticus ATCC 31121 (48) ; but an understanding of their active role in determining resistance is only at the beginning. van-like genes are physically linked to the gene clusters for the biosynthesis of A47934 (43) and teicoplanin (tcp cluster) (48, 49) , but this does not seem to be the case in the other glycopeptide producers so far characterized (14) . When the vanA gene of Streptomyces toyocaensis (vanA st ; vanA homolog) was disrupted, the mutant showed reduced resistance to A47934 but continued to produce this compound with a delay of ca. 16 h in comparison with that for the parental strain (43) . One end of the tcp cluster contains seven genes likely involved in teicoplanin resistance: murF2; the vanH, vanA, and vanX genes of A. teichomyceticus (vanH at , vanA at , and vanX at , respectively); the sensory kinase and the response regulator of a putative two-component signal transduction system (orthologous to the vanS and vanR genes of enterococci); and a shortchain dehydrogenase of unknown function (29, 49) . These seven genes of A. teichomyceticus were cloned in Streptomyces coelicolor, but their effect on the teicoplanin resistance of the recipient strain was marginal (47, 48) . On the other hand, van-like genes conferring resistance to vancomycin but not to teicoplanin were found in S. coelicolor itself, even though this strain lacks the genetic potential to produce glycopeptides (8, 20) .
The purpose of this paper is to clarify the role of van genes in the resistance mechanisms used by the teicoplanin producer A. teichomyceticus during the phases of vegetative growth and the production of teicoplanin. Besides the genetic evidence for the presence of van-like genes, no insight into the resistance phenotype of A. teichomyceticus has so far been reported. The complex life cycle, the need for properly tailored microbiological methods in handling this rare actinomycete, and the lack of suitable genetic manipulation tools have probably hampered, until now, a comprehensive understanding of resistance comparable to that achieved for pathogenic enterococci.
MATERIALS AND METHODS
Strains and growth conditions. The mycelium of the teicoplanin producer strain A. teichomyceticus ATCC 31121 was maintained as a lyophilized master cell bank. Mycelium from the master cell bank was streaked onto slants of salt medium (SM; glucose [Sigma-Aldrich, St. Sigma-Aldrich). After growth, the mycelium from a slant was homogenized in 10 ml of isotonic saline and inoculated in SM, grown for 96 h at 28°C with aeration, and stored as working cell bank (WCB) in 1.5-ml cryovials at Ϫ80°C for further experiments. The WCB was used to inoculate all the cultures for the experiments described here. Unless otherwise specified, the cultures were grown in medium (SM or SM agar) in which the production of teicoplanin did not occur, as demonstrated by high-pressure liquid chromatography (HPLC) analysis of the culture extracts, as reported below. These cultures/media are defined here as vegetative to distinguish them from productive cultures/media which did support teicoplanin production.
For DNA/RNA extraction, 2 ml WCB was inoculated into 100 ml of SM in a 500-ml baffled flask to which 5 ml sterile glass beads was added, and the flask was incubated at 28°C for 72 h on a rotary shaker at 200 rpm. Mycelium from this seed culture was transferred into 100 ml fresh SM to give an inoculum density of 10 g/liter (wet weight), and growth was allowed for 24 h at 28°C and 200 rpm. Vancomycin (Sigma-Aldrich) or teicoplanin (Sanofi-Aventis, Paris, France) was added, when required, at subinhibitory concentrations of 30 g/ml and 4 g/ml, respectively.
DNA/RNA extraction. Genomic DNA of A. teichomyceticus ATCC 31121 was extracted by a previously described method (24) from an SM vegetative culture grown to the exponential phase (24 to 48 h). RNA was extracted from mycelium induced for 1, 2, 4, 8, and 24 h with vancomycin or teicoplanin. Control samples to which glycopeptide was not added were extracted at the same time intervals. Mycelium was incubated in 2 ml of Tris-EDTA buffer containing 10 mg/ml lysozyme (Sigma-Aldrich) for 10 min; then, RNA isolation was carried out by following the protocol for the TRIzol reagent (Invitrogen, Carlsbad, CA). For further purification, an RNeasy Midi kit (QIAGEN, Hilden, Germany) was used according to the supplier's instructions. Residual DNA from RNA samples was removed by incubation with 10 U RNase-free DNase I (Roche, Basel, Switzerland) at 37°C for 1 h. The DNase I was then extracted with phenol and chloroform-isoamyl alcohol (24:1; Sigma-Aldrich). Finally, the RNA was recovered by ethanol-sodium acetate precipitation and centrifugation and was stored at Ϫ80°C in diethyl pyrocarbonate (Sigma-Aldrich)-treated water at a final concentration of 1 g/l.
Genetic analyses. DNA manipulations were performed by standard methods (46) unless otherwise specified. The positions reported for PCR and cDNA synthesis primers refer to the sequence in the GenBank database with accession no. AJ605139. Total RNA samples from the different cultivation conditions were accurately quantified with a UV 2100 spectrophotometer (Shimadzu, Kyoto, Japan) and normalized by direct comparison on 1% agarose electrophoresis gels (Sigma-Aldrich). Five micrograms of each RNA sample was reverse transcribed by using the SuperScript first-strand synthesis system for reverse transcription-PCR (RT-PCR; Invitrogen). The first-strand synthesis reaction was primed with random hexamers for 1 h at 37°C. Different cDNA concentrations were then used as the template for amplification of vanX at with primers vanXFw (position 14301-5Ј-TTCGCGTTCGTGGACGAG-3Ј-position 14319) and vanXRev (position 14897-5Ј-CTACACGATCGGAAAATCAAA-3Ј-position 14876); vanA at was amplified with primers vanAFw (position 13269-5Ј-CGGCATCATCTTCGGCG-3Ј-position 13286) and vanARev (position 14273-5Ј-AGGGCCAGCGACACGA T-3Ј-position 14256); and vanH at was amplified with primers vanHFw (position 12057-5Ј-AGCGCGGACGCCATCCGT-3Ј-position 12075) and vanHRev (position 13256-5Ј-CCCATGCTGTTGTTCCCT-3Ј-position 13238). Chromosomal DNA of A. teichomyceticus ATCC 31121 was used as a positive control, and total RNA without first-strand synthesis was used to test for genomic DNA contamination. The amplification products were separated on a 1% agarose gel. Semiquantitative PCR of the vanX at gene was performed as reported previously (36) . In brief, 1:2 serial dilutions of the RNA reverse transcription product were amplified as described above with primers vanXFw and vanXRev by using 25 instead of 30 amplification cycles in order to compare the products during the exponential phase of the PCR and to quantify the relative mRNA levels. Samples were separated on a 1% agarose gel, and the relative transcript amount was determined by densitometric quantification with MI Image Analysis software (Kodak, Rochester, NY). In order to ensure that the amount of total cDNA was the same in the different samples, the same set of cDNA dilutions used as the template for the vanX at gene was also used to amplify the 16S rRNA genes.
Reverse transcription of the putative van operon encompassing the vanH at , vanA at , and vanX at genes was carried out by using 5 g of total RNA as the template and the gene-specific primer vanXRev. Different cDNA concentrations were used as the template for PCR amplification with primers TevanHFw (position 12886-5Ј-CACTTCACACCCCGCTCA-3Ј-position 12904), which maps 844 bp downstream from the VanH at putative start, and TevanXRev (position 14639-5Ј-GCTGTGACCGGACTTGGT-3Ј-position 14620), which is located 351 bp downstream from the VanX at putative start. The conditions for amplification were as described above. Chromosomal DNA of A. teichomyceticus ATCC 31121 was used as the positive control, and total RNA without first-strand synthesis was used to test for genomic DNA contamination. The amplification product was analyzed on a 1% agarose gel.
Sequence homology analysis was performed with the BLAST program, and protein multisequence alignment was performed with the Clustal X program.
Antimicrobial activity assays. The MICs of teicoplanin and vancomycin were determined by the broth microdilution methodology, according to the procedures of the CLSI (formerly the NCCLS) (37) , which were adapted to the cultivation conditions and the duplication times of A. teichomyceticus ATCC 31121. Vegetative mycelium grown to the exponential phase (24 to 48 h) in SM was harvested by centrifugation; suspended in isotonic saline; and fragmented by 1136 BELTRAMETTI ET AL. ANTIMICROB. AGENTS CHEMOTHER.
sonication with a VCX 400 sonicator (Sonics and Materials Inc., Newtown, CT) at an intensity of 6 kHz and with the pulse on for 5 s and the pulse off for 3 s for a total interval sufficient to give single unbranched hyphae with sizes ranging from 1 to 5 m (the sizes were checked with a microscope). The resulting cell suspension was filtered through a 5-m-pore-size Durapore membrane filter (Millipore, Bedford MA), harvested by centrifugation, suspended in fresh SM at a concentration of 10 g/liter (fresh weight), and dispensed in a set of flasks containing vancomycin or teicoplanin at different concentrations. Growth was allowed for 96 h at 28°C with shaking. The MIC was the first antibiotic concentration that afforded no visible growth after 96 h of incubation. Induction of glycopeptide resistance was investigated as follows. Mycelium was grown in SM medium for 24 h at 28°C. Then, subinhibitory concentrations of vancomycin (30 g/ml) or teicoplanin (4 g/ml) were added to the culture and growth was allowed for a further 24 h. Finally, the vegetative mycelium was sonicated and dispensed in flasks for MIC determination, as described above.
For the determination of the minimal bactericidal concentration, the sonicated vegetative mycelium was inoculated in a set of flasks containing increasing antibiotic concentrations and the flask was incubated at 28°C with shaking for a time interval equal to three generations (approximately 24 h), which was estimated in SM without any antibiotic. Mycelium from each flask was then washed with isotonic saline, diluted, and plated on SM agar plates without added antibiotic. After 15 days at 28°C, the fraction of cells which survived in the presence of the respective antibiotic concentrations in the flask and which were thus able to grow on a plate was determined. Antibiotic concentrations that resulted in a percentage of survivors less than 0.1 were considered bactericidal (27) .
Teicoplanin production. Two milliliters of A. teichomyceticus WCB was inoculated in SM and grown for 72 h at 28°C on a rotary shaker at 200 rpm. Ten milliliters of this vegetative culture was then transferred to 100 ml of production medium C (glucose The culture samples were centrifuged (16,000 ϫ g for 15 min) in graduated vials and decanted, and 1 volume of packed mycelium was suspended in 3 volumes of borate buffer. The supernatant was then filtered as described above. Glycopeptide production was estimated by HPLC, which was performed on a 5-mparticle-size Ultrasphere ODS (Beckman Coulter Inc., Fullerton, CA) column (4.6 by 250 mm) with elution at a flow rate of 1 ml/min with a 26-min linear gradient from 25% to 37% phase B. Phase A was 20 mM HCOONH 4 (pH 4.5; Sigma-Aldrich) and CH 3 CN (Sigma-Aldrich) (95:5 [vol/vol]), and phase B was 20 mM HCOONH 4 (pH 4.5) and CH 3 CN (5:95 [vol/vol]). Chromatography was performed with a model 1100 HPLC system (Hewlett-Packard, Palo Alto, CA), and UV detection was at 254 nm. Pure samples of teicoplanin (Sanofi-Aventis) were used as the internal standard. For growth estimation, mycelium was collected by centrifugation (3,250 ϫ g for 20 min) and was washed with 2 ml isotonic saline. The dry weight was measured after 24 h of incubation in an 80°C oven. For MIC determination during teicoplanin production, 10 g/liter of mycelium was transferred from fermentative medium C to vegetative SM in the presence of increasing teicoplanin concentrations. The effective antibiotic concentration in the MIC flasks was the sum of the teicoplanin concentration added and the concentration of teicoplanin produced and carried over into the mycelium. Fermentations, growth estimations, and MIC determinations were performed in triplicate.
Peptidoglycan precursor extraction and analysis. A. teichomyceticus ATCC 31121 peptidoglycan precursors were extracted by a method previously described for Bacillus cereus (25) , with some modification. Briefly, mycelium grown in vegetative medium to the exponential phase (24 to 48 h) was incubated for 1 h with 150 g/ml ramoplanin (ca. eightfold the ramoplanin MIC; Biosearch Italia SpA, Gerenzano, Italy) to block final assembly of the cell wall and thus to amplify the cytoplasmic pool of uridine diphospho-linked precursors (6) . Then, the cells were harvested, suspended in water (0.1 g [fresh weight] per ml), and boiled for 20 min. After the mycelium was first cooled at room temperature and then in ice, it was centrifuged at 39,000 ϫ g. The supernatant was lyophilized and dissolved in 0.1 volume of water adjusted to pH 3 with formic acid. The samples were analyzed by reversed-phase HPLC and electrospray ionization (ESI)-mass spectrometry (MS) on a LCQ-Deca spectrometer equipped with an ion-trap analyzer (Thermo Finnigan, San Jose, CA). The samples were separated on a C 18 column (5 m; 4.6 by 250 mm; Phenomenex Luna, Torrance, CA) eluted at a flow rate of 1 ml/min with 2 min with 100% phase A and then a 50-min linear gradient to 100% phase B. Phase A was 2% CH 3 CN, 97.9% H 2 O, 0.1% HCOOH (vol/vol/ vol); and phase B was 95% CH 3 CN, 4.915% H 2 O, and 0.085% HCOOH (vol/ vol/vol). The column temperature was 22°C. The chromatographic UV absorption profile was provided with a photo diode array detector (UV6000; Thermo Finnigan). One-fifth of the detector elution flow was split into the mass spectrometer. The MS spectra were obtained by electrospray ionization both in the positive mode and in the negative mode under the following conditions. Sample inlet conditions were as follows: capillary temperature, 250°C; sheath gas (N 2 ), 80 LCQ arbitrary units; and auxiliary gas (N 2 ), 20 LCQ arbitrary units. Sample inlet voltage settings were as follows: positive polarity, 4.5 kV; negative polarity, 2.8 kV; capillary voltage, 4 V; and tube lens offset, 30 V. Helium was used as the buffer and collision gas. MS-MS analyses were performed at a collision energy of 30 keV. All the spectra were acquired in the 150-to 2,000-atomic-mass-unit mass range.
RESULTS AND DISCUSSION
Organization and transcription of van genes in A. teichomyceticus. In A. teichomyceticus ATCC 31121, van gene homologs were found in a region contiguous with the tcp cluster (47) (48) (49) . In the present study we have analyzed by RT-PCR the expression of van genes during growth in vegetative medium. Under these conditions, A. teichomyceticus did not produce detectable quantities of teicoplanin (HPLC detection limit, 0.1 mg/liter) which could eventually induce the van genes and, consequently, interfere with the investigation of gene expression. First, qualitative monitoring of transcription indicated that the vanA at and vanX at genes are always transcribed, independently of whether exogenous vancomycin or teicoplanin is added or not added as an inducer (data not shown). Amplification of the cDNA obtained with primers TevanHFw and TevanXRev (mapping 373 bp upstream from the stop codon of vanH and 350 bp downstream from the start codon of vanX, respectively) indicated that the vanH at , vanA at , and vanX at genes are cotranscribed in an unique polycistronic mRNA (data not shown). Next, the van transcript levels of cultures grown either for 8 h or for 24 h in the presence of exogenously added vancomycin (30 g/ml) or teicoplanin (4 g/ml) were compared to those of cultures grown in the absence of the glycopeptides by semiquantitative RT-PCR with primers vanXFw and vanXRev. The subinhibitory glycopeptide concentrations used (previously defined in MIC experiments; see below) did not influence the growth rate of A. teichomyceticus. Densitometric analysis of the RT-PCR products obtained from the vancomycin-and teicoplanin-induced cultures showed that for each dilution of the cDNA template, the amounts of the amplification products corresponding to the vanX at transcript were essentially comparable to those achieved in uninduced cultures (data not shown). Vancomycin-induced cultures showed only a slightly (twofold) greater amount of transcript at 8 h, but this difference was no longer apparent after 24 h of induction. These results suggest the constitutive transcription of the A. teichomyceticus van cluster.
Mutations in A. teichomyceticus VanS suggest impaired activity of the sensor kinase. Constitutive expression of the van genes determined by mutation of the VanS sensor kinase has been reported for glycopeptide-resistant enterococci and, recently, for S. coelicolor (5, 7, 13, 22) . We have taken advantage of the high degree of identity (77%) between the VanS sequences of S. coelicolor (EMBL accession no. AL939117.1) and A. teichomyceticus (EMBL accession no. AJ632270.1) to check for the presence and significance of possible mutations in the VanS protein of A. teichomyceticus. By sequence alignment, we found two significant amino acid differences, located at positions 215 and 270 (positions 216 and 271, respectively, in S. coelicolor). Amino acids L216 and G271, located in the ATPase domain of VanS, have been reported to be crucial for the VanS phosphorylase activity in S. coelicolor, since their mutation (L216P and G271V) resulted in constitutive van gene expression and subsequent constitutive resistance (22) . The differences in these amino acids (L216 and G271 of S. coelicolor have the orthologs N215 and R270, respectively, in A. teichomyceticus) suggest that A. teichomyceticus also has an impaired phosphatase function. In this actinomycete, a mutated VanS homolog conferring constitutive glycopeptide resistance may have been selected as an adaptation to teicoplanin production. Previous results on the marginal effect of cloning of A. teichomyceticus van genes in S. coelicolor (47) to teicoplanin resistance are likely due to complementation by the fully functional VanS homolog of S. coelicolor, which maintains an inducible phenotype of vancomycin resistance and teicoplanin sensitivity.
Resistance to vancomycin and teicoplanin in A. teichomyceticus. Detailed studies of the resistance phenotypes of glycopeptide-producing microorganisms are not reported in the literature. The standard method used to determine MICs for mycelial actinomycetes is hampered by the formation of multicellular aggregates and by the copresence of cells in different differentiation phases (i.e., vegetative mycelium, aerial mycelium, and spores) (35) . We obtained hyphal preparations that could be converted to dispersed bacterial populations by use of a properly balanced protocol of sonication/filtration that was able to disrupt pellets and detach small hyphal fragments without damaging cell integrity. Under these conditions, A. teichomyceticus was resistant to glycopeptides, showing MICs of teicoplanin and vancomycin of 25 g/ml and 90 g/ml, respectively. These levels of glycopeptide resistance resemble those reported for intermediately resistant pathogenic enterococci, such as VanD isolates (42) . The growth of A. teichomyceticus in the presence of teicoplanin or vancomycin at subinhibitory concentrations before MIC determination did not cause any changes in the MICs.
Determination of structures of peptidoglycan precursors. In enterococci the expression of van genes redirects cell wall biosynthesis toward the modified UDP-muropentapeptides (42) . To characterize the cell wall precursors in A. teichomyceticus ATCC 31121, cell wall assembly was blocked by the addition of ramoplanin, as reported in the literature (2) . This depsipeptide antibiotic is structurally unrelated to vancomycin and teicoplanin, inhibits peptidoglycan transglycosylases (21) , and is devoid of any effect on the induction of van gene expression in Enterococcus faecalis and S. coelicolor (6, 22) . The cell wall precursor pool in ramoplanin-treated cells was analyzed by liquid chromatography (LC)-MS. A major peak was found to elute at a retention time of 17.8 min (Fig. 1B) . As untreated cells did not exhibit this peak (Fig. 1A) , it thus appeared to be related to a cell wall precursor that accumulated as a result of the effect of ramoplanin. The positive-ion ESI-MS spectrum corresponding to this peak revealed the presence of two quasimolecular ions,
, at m/z 1196.9 and 1212.9 (data not shown). The negative-ion spectrum ( Fig. 2A) Fig. 2C) . This depsipeptide contains the D-Ala-D-Lac terminus characteristic of the VanA, VanB, and VanD phenotypes (42) and a remaining part consistent with data in the literature (23) . In fact, in Actinoplanes species and in some other actinomycetes, the glycolyl group is present instead of acetyl groups in muramic acid and the composition of the peptide unit is glycine, glutamic acid, meso-diaminopimelic acid (or meso-3-hydroxy-diaminopimelic acid), and alanine (23) . The difference of 16 mass units between the molecular mass of the two species which coelute by LC-MS at 17.8 min suggests the presence of a hydroxy group on the UDP-Nglycomuramyl-Gly-D-Glu-mDap-D-Ala-D-Lac, probably on the meso-diaminopimelic acid (indicated by R in Fig. 2C Ϫ at m/z 1194) were detected (Fig. 2) . This further confirms that the van genes are constitutively expressed in A. teichomyceticus. We cannot rule out the possibility that peptidoglycan precursors terminating in D-Ala-D-Ala are also synthesized, but in this case they should be very efficiently and completely converted to the D-Ala-D-Lac-terminating ones. These data, together with those on the constitutive transcription of van genes in RT-PCR experiments and with the MICs of either vancomycin or teicoplanin, define a constitutive phenotype of glycopeptide resistance in A. teichomyceticus with features similar to those described in VanD enterococci. In fact, VanD enterococci are intermediately resistant to vancomycin and teicoplanin, their van genes are constitutively transcribed, and the UDP-muropentapeptide terminates with DAla-D-Lac independently from the presence of glycopeptides in the cultivation medium (41) .
Teicoplanin production and glycopeptide resistance. Resistance could be coregulated with endogenous antibiotic production in antibiotic-producing microorganisms, and an increase of self-resistance during antibiotic production has been reported previously (12) . The proximity of the van genes to the tcp cluster in A. teichomyceticus may imply some mechanism of coregulation (47) (48) (49) . Figure 3 shows the correlations among growth, teicoplanin production, and MIC at different times of A. teichomyceticus cultivation in the antibiotic production medium. The teicoplanin MIC at the beginning of fermentation was the same as that in vegetative cultures (25 g/ml), and then 
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A. TEICHOMYCETICUS van-MEDIATED GLYCOPEPTIDE RESISTANCE 1139 it showed a slight, transient increase (33 g/ml) at the end of the exponential phase of growth and finally decreased during the stationary phase, in association with maximal antibiotic production. At 48 h after inoculation (exponential phase of growth), teicoplanin was produced at about 20 g/ml and reached 70 to 80 g/ml at 96 h of fermentation (stationary phase of growth). Because glycopeptides are reported to exert bactericidal actions in pathogens (26) , the minimal bactericidal concentrations of teicoplanin and vancomycin were determined. In A. teichomyceticus more than 20% of the population survived 24 h of exposure to teicoplanin at 5,000 g/ml, and treatment with the same vancomycin concentration allowed 50% survival. The control antibiotic kanamycin showed, instead, bactericidal action at much lower concentrations (data not shown).
It can be concluded that teicoplanin as well as vancomycin is not bactericidal for A. teichomyceticus. Thus, this microorganism fails to grow in the presence of more than 25 g/ml of teicoplanin but could resume growth if the antibiotic is removed. The maximum level of teicoplanin production (80 g/ ml) in submerged cultures is higher than the MIC, but teicoplanin production occurs in the late exponential-stationary phase of growth, when scarce mycelium proliferation is reported. Under these physiological conditions, the activity of cell wall biosynthesis per se is reduced. The mechanisms of van-mediated resistance appear to be involved in the phase of active growth, when the levels of teicoplanin production are usually at sub-MICs. As the strain enters into the stationary phase, resistance is no longer required and the nonproliferating cells are tolerant to high concentrations of their own product. When Pootoolal and coworkers (43) knocked out the vanA-like gene conferring A47934 resistance to the producer strain S. toyocaensis NRRL15009, the mutant retained the ability to produce the antibiotic, but its production was delayed for more than 16 h. Probably, also in this case, antibiotic production was delayed to a period when cells have ceased growing and are predicted to become insensitive to antibiotic action.
Analysis of the temporal succession of growth and resistance, antibiotic production, and tolerance in A. teichomyceticus brings our attention back to the complex life cycle of this nonmotile saprophytic filamentous soil actinomycete, which grows by colonizing solid substrates with vegetative hyphal mass and then differentiates into aerial structures with motile spores that assist species spread and persistence. In nature, antibiotic production starts when the growth of the vegetative mycelium slows down as a result of nutrient exhaustion and secondary structures evolve at the expense of the nutrients released by the breakdown of vegetative cells at the center of the colony. It has been proposed that antibiotics defend the food source from the threat of competitors, without damaging the cells that differentiate into spores, which should tolerate high local concentrations. Meanwhile, the expression of antibiotic resistance genes may be an advantage to mycelium that is still growing at the borders of the colony, where the antibiotic diffuses at low concentrations from the center. In conclusion, resistance allows the growth and spread of vegetative mycelium, while antibiotic production protects the center of the colony, which has switched to the sporulating phase.
